BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22290292)

  • 1. The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.
    Gherezghiher TB; Michalsen B; Chandrasena RE; Qin Z; Sohn J; Thatcher GR; Bolton JL
    Chem Biol Interact; 2012 Mar; 196(1-2):1-10. PubMed ID: 22290292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone.
    Zhang F; Chen Y; Pisha E; Shen L; Xiong Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 1999 Feb; 12(2):204-13. PubMed ID: 10027800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol.
    Michalsen BT; Gherezghiher TB; Choi J; Chandrasena RE; Qin Z; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2012 Jul; 25(7):1472-83. PubMed ID: 22642258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
    Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
    Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
    Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
    Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens.
    Chang M; Zhang F; Shen L; Pauss N; Alam I; van Breemen RB; Blond SY; Bolton JL
    Chem Res Toxicol; 1998 Jul; 11(7):758-65. PubMed ID: 9671538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and reactivity of the catechol metabolites from the equine estrogen, 8,9-dehydroestrone.
    Zhang F; Yao D; Hua Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2001 Jun; 14(6):754-63. PubMed ID: 11409947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivation of the selective estrogen receptor modulator desmethylated arzoxifene to quinoids: 4'-fluoro substitution prevents quinoid formation.
    Liu H; Liu J; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2005 Feb; 18(2):162-73. PubMed ID: 15720120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone.
    Zhang F; Fan PW; Liu X; Shen L; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):53-62. PubMed ID: 10649967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine peroxidase-catalyzed formation of diquinone methides from the selective estrogen receptor modulators raloxifene and desmethylated arzoxifene.
    Liu H; Qin Z; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2007 Nov; 20(11):1676-84. PubMed ID: 17630709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
    Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
    Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the p-alkyl substituent on the isomerization of o-quinones to p-quinone methides: potential bioactivation mechanism for catechols.
    Iverson SL; Hu LQ; Vukomanovic V; Bolton JL
    Chem Res Toxicol; 1995 Jun; 8(4):537-44. PubMed ID: 7548733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells.
    Peng KW; Wang H; Qin Z; Wijewickrama GT; Lu M; Wang Z; Bolton JL; Thatcher GR
    ACS Chem Biol; 2009 Dec; 4(12):1039-49. PubMed ID: 19839584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
    Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
    Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases.
    Zhang F; Swanson SM; van Breemen RB; Liu X; Yang Y; Gu C; Bolton JL
    Chem Res Toxicol; 2001 Dec; 14(12):1654-9. PubMed ID: 11743748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes.
    Iverson SL; Shen L; Anlar N; Bolton JL
    Chem Res Toxicol; 1996 Mar; 9(2):492-9. PubMed ID: 8839054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation.
    Chen Q; Ngui JS; Doss GA; Wang RW; Cai X; DiNinno FP; Blizzard TA; Hammond ML; Stearns RA; Evans DC; Baillie TA; Tang W
    Chem Res Toxicol; 2002 Jul; 15(7):907-14. PubMed ID: 12119000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides.
    Liu J; Liu H; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2005 Feb; 18(2):174-82. PubMed ID: 15720121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen dependent mammary gland virilism in rats given the selective estrogen receptor modulator LY2066948 hydrochloride.
    Rudmann DG; Cohen IR; Robbins MR; Coutant DE; Henck JW
    Toxicol Pathol; 2005; 33(6):711-9. PubMed ID: 16263696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.